Neoadjuvant Treatment of Duodenal Adenocarcinoma: A Rescue Strategy

Journal of Gastrointestinal Surgery

Volumn 16, Issue 2, 2012, Pages 320-324

  Onkendi, Edwin O ^a   Boostrom, Sarah Y ^a   Sarr, Michael G ^a   Farnell, Michael B ^a   Nagorney, David M ^a   Donohue, John H ^a   Kendrick, Michael L ^a   Lombardo, Kaye M Reid ^a   Haddock, Michael G ^a   Que, Florencia G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Duodenal adenocarcinoma; Neoadjuvant therapy; Unresectable

Indexed keywords

ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; DUODENUM; DUODENUM TUMOR; EVALUATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; DUODENAL NEOPLASMS; DUODENUM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84856218792     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1667-7     Document Type: Article

References (10)

1. Bakaeen FG, Murr MM, Sarr MG, et al.: What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 2000; 135: 635-641; discussion 641-632.
2. Solej M, D'Amico S, Brondino G, et al.: Primary duodenal adenocarcinoma. Tumori 2008; 94: 779-786.
3. Eisenhauer EA, Therasse P, Bogaerts J, et al.: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1. 1). Eur J Cancer 2009; 45: 228-247.
4. Alwmark A, Andersson A, Lasson A: Primary carcinoma of the duodenum. Ann Surg 1980; 191: 13-18.
5. Dabaja BS, Suki D, Pro B, et al.: Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004; 101: 518-526.
6. Struck A, Howard T, Chiorean EG, et al.: Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol 2009; 100: 144-148.
7. Struck A, Howard T, Chiorean EG, et al.: Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol 2009; 100: 144-148.
8. Kelsey CR, Nelson JW, Willett CG, et al.: Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys 2007; 69: 1436-1441.
9. Yeung RS, Weese JL, Hoffman JP, et al.: Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study. Cancer 1993; 72: 2124-2133.
10. Coia L, Hoffman J, Scher R, et al.: Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys 1994; 30: 161-167.